Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 3

Sponsor Class

NETWORK 2OTHER 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Thoracic 3

Conditions

Leukemia 10Breast Neoplasms 10Prostatic Neoplasms 8Lymphoma, Follicular 8Lymphoma 8Carcinoma, Non-Small-Cell Lung 7Lung Neoplasms 6Adenocarcinoma of Lung 5Rectal Neoplasms 4Multiple Myeloma 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Lymphocytic, Chronic, B-Cell 4Kidney Neoplasms 4Hodgkin Disease 4Congenital Abnormalities 4Colorectal Neoplasms 4Colonic Neoplasms 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neuroblastoma 3Neoplasms, Plasma Cell 3Myeloproliferative Disorders 3Myelodysplastic Syndromes 3Lymphoma, Non-Hodgkin 3Lymphoma, Mantle-Cell 3Lymphoma, Extranodal NK-T-Cell 3Leukemia, Myeloid, Acute 3Burkitt Lymphoma 3Adenocarcinoma, Bronchiolo-Alveolar 3

Interventions

Carboplatin 23Paclitaxel 18Bevacizumab 16Radiotherapy 15Erlotinib Hydrochloride 13Cisplatin 9Gemcitabine 7Gefitinib 7Docetaxel 7Taxes 6Pemetrexed 6Cetuximab 4Etoposide 3Amplified Fragment Length Polymorphism Analysis 3pegfilgrastim 2Vinorelbine 2Topotecan 2Radiotherapy, Conformal 2Radiation 2Irinotecan 2Gene Expression Profiling 2Anterior Temporal Lobectomy 2vandetanib 1sargramostim 1romidepsin 1lentiviral minigene vaccine of COVID-19 coronavirus 1irofulven 1cositecan 1advexin 1Video-Assisted Surgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Adenocarcinoma, Bronchiolo-Alveolar × Amplified Fragment Length Polymorphism Analysis × Clear all
NCT01557959 2018-06-29

Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Wake Forest University Health Sciences

Phase 2 Completed
45 enrolled 9 charts
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung

NCT00897533 2017-05-19

Development of a Model to Predict Progression-Free Survival After Erlotinib in Patients With Non-Small Cell Lung Cancer

Eastern Cooperative Oncology Group

Completed
137 enrolled
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00900172 2017-05-19

Study of Blood and Tissue Samples From Patients With Locally Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer Treated With Bevacizumab, Carboplatin, and Paclitaxel

Eastern Cooperative Oncology Group

Completed
180 enrolled
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡